Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 2:43 PM
Ignite Modification Date:
2025-12-26 @ 2:43 PM
NCT ID:
NCT07029906
Eligibility Criteria:
Inclusion Criteria:
* Heart failure with index LVEF \<40%
* Not currently taking beta-blocker tablets
* Previously tried one of beta-blocker tablet, and stopped taking it due to symptoms attributed to the beta-blocker
* Consenting to participate in the study
Exclusion Criteria:
* Documented anaphylaxis to beta-blockers
* Clinical contraindication to Bisoprolol including (but not limited to):
1. Asthma requiring BTS treatment step 3 or higher
2. Marked bradycardia (\<50 bpm)
3. Symptomatic hypotension (systolic BP \<85mmHg)
4. Metabolic acidosis
5. Phaeochromocytoma
6. 1st degree heart block with PR interval \>250ms
7. 2nd degree or complete heart block
8. Sick sinus syndrome
9. Acute pulmonary oedema
* Life expectancy \<1 year
* Patient refusal or inability to participate in the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07029906
Study Brief:
Protocol Section:
NCT07029906